Establishment Labs [ESTA] vs Artivion [AORT] Detailed Stock Comparison
Establishment Labs
NASDAQ
Loading...
Artivion
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Establishment Labs wins in 3 metrics, Artivion wins in 15 metrics, with 0 ties. Artivion appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Establishment Labs | Artivion | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -13.81 | -128.28 | Artivion |
| Price-to-Book Ratio | 52.71 | 4.61 | Artivion |
| Debt-to-Equity Ratio | 993.34 | 62.81 | Artivion |
| PEG Ratio | 1.71 | 0.80 | Artivion |
| EV/EBITDA | -25.39 | 47.17 | Establishment Labs |
| Profit Margin (TTM) | -49.89% | -4.43% | Artivion |
| Operating Margin (TTM) | -27.50% | 9.72% | Artivion |
| EBITDA Margin (TTM) | N/A | 9.72% | N/A |
| Return on Equity | -261.18% | -5.02% | Artivion |
| Return on Assets (TTM) | -12.78% | 1.70% | Artivion |
| Free Cash Flow (TTM) | $-74.08M | $11.05M | Artivion |
| 1-Year Return | -1.26% | 57.21% | Artivion |
| Price-to-Sales Ratio (TTM) | 6.77 | 4.78 | Artivion |
| Enterprise Value | $1.37B | $2.15B | Artivion |
| EV/Revenue Ratio | 7.73 | 5.30 | Artivion |
| Gross Profit Margin (TTM) | 68.76% | 64.72% | Establishment Labs |
| Revenue per Share (TTM) | $6 | $10 | Artivion |
| Earnings per Share (Diluted) | $-3.08 | $-0.43 | Artivion |
| Beta (Stock Volatility) | 0.86 | 1.67 | Establishment Labs |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Establishment Labs vs Artivion Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Establishment Labs | -5.07% | -4.93% | 2.85% | -14.70% | 25.65% | -13.14% |
| Artivion | -0.73% | -3.07% | -6.19% | 34.53% | 76.48% | 45.12% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Establishment Labs | -1.26% | -29.48% | 115.51% | 49.03% | 49.03% | 49.03% |
| Artivion | 57.21% | 291.07% | 112.02% | 292.58% | 518.36% | 483.81% |
News Based Sentiment: Establishment Labs vs Artivion
Establishment Labs
News based Sentiment: NEUTRAL
The month's events centered around financial maneuvering – securing debt and adjusting liquidity requirements – alongside routine equity compensation for a director. While these actions improve financial flexibility and director alignment, they don't fundamentally alter the company's profitability challenges, resulting in a neutral overall investment story.
Artivion
News based Sentiment: MIXED
October was a mixed month for Artivion, with a significant earnings beat and positive analyst revisions offset by notable insider selling and fluctuating stock performance. The combination of positive financial results and concerning insider activity creates a complex investment narrative, making it a moderately important month for investors.
Performance & Financial Health Analysis: Establishment Labs vs Artivion
| Metric | ESTA | AORT |
|---|---|---|
| Market Information | ||
| Market Cap | $1.20B | $1.98B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 313,209 | 388,190 |
| 90 Day Avg. Volume | 267,386 | 443,357 |
| Last Close | $39.33 | $40.75 |
| 52 Week Range | $26.56 - $50.85 | $21.97 - $45.07 |
| % from 52W High | -22.65% | -9.59% |
| All-Time High | $93.80 (Apr 18, 2022) | $45.07 (Aug 22, 2025) |
| % from All-Time High | -58.07% | -9.59% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.16% | 0.15% |
| Quarterly Earnings Growth | 0.16% | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | -0.50% | -0.04% |
| Operating Margin (TTM) | -0.28% | 0.10% |
| Return on Equity (TTM) | -2.61% | -0.05% |
| Debt to Equity (MRQ) | 993.34 | 62.81 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $0.79 | $8.91 |
| Cash per Share (MRQ) | $1.89 | $1.13 |
| Operating Cash Flow (TTM) | $-72,688,000 | $19.65M |
| Levered Free Cash Flow (TTM) | $-39,815,124 | $-12,697,875 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Establishment Labs vs Artivion
| Metric | ESTA | AORT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -13.81 | -128.28 |
| Forward P/E | -25.11 | 171.04 |
| PEG Ratio | 1.71 | 0.80 |
| Price to Sales (TTM) | 6.77 | 4.78 |
| Price to Book (MRQ) | 52.71 | 4.61 |
| Market Capitalization | ||
| Market Capitalization | $1.20B | $1.98B |
| Enterprise Value | $1.37B | $2.15B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 7.73 | 5.30 |
| Enterprise to EBITDA | -25.39 | 47.17 |
| Risk & Other Metrics | ||
| Beta | 0.86 | 1.67 |
| Book Value per Share (MRQ) | $0.79 | $8.91 |
Financial Statements Comparison: Establishment Labs vs Artivion
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ESTA | AORT |
|---|---|---|
| Revenue/Sales | $51.30M | $112.97M |
| Cost of Goods Sold | $16.03M | $39.86M |
| Gross Profit | $35.27M | $73.11M |
| Research & Development | $5.20M | $7.06M |
| Operating Income (EBIT) | $-14.11M | $8.38M |
| EBITDA | $-7.04M | $18.95M |
| Pre-Tax Income | $-15.59M | $3.48M |
| Income Tax | $1.00M | $2.14M |
| Net Income (Profit) | $-16.59M | $1.35M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ESTA | AORT |
|---|---|---|
| Cash & Equivalents | $69.18M | $37.69M |
| Total Current Assets | $231.70M | $287.30M |
| Total Current Liabilities | $69.04M | $51.94M |
| Long-Term Debt | $224.14M | $356.98M |
| Total Shareholders Equity | $38.55M | $294.25M |
| Retained Earnings | $-465.40M | $-61.77M |
| Property, Plant & Equipment | $5.19M | $77.04M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ESTA | AORT |
|---|---|---|
| Operating Cash Flow | $-24.24M | $-17.94M |
| Capital Expenditures | $-753,000 | N/A |
| Free Cash Flow | $-21.75M | $-20.59M |
| Debt Repayment | N/A | $-66,000 |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ESTA | AORT |
|---|---|---|
| Shares Short | 5.10M | 1.08M |
| Short Ratio | 18.92 | 2.52 |
| Short % of Float | 0.26% | 0.03% |
| Average Daily Volume (10 Day) | 313,209 | 388,190 |
| Average Daily Volume (90 Day) | 267,386 | 443,357 |
| Shares Outstanding | 28.79M | 41.95M |
| Float Shares | 16.95M | 41.61M |
| % Held by Insiders | 0.11% | 0.05% |
| % Held by Institutions | 1.08% | 0.90% |
Dividend Analysis & Yield Comparison: Establishment Labs vs Artivion
| Metric | ESTA | AORT |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | $0.00 |
| Ex-Dividend Date | N/A | N/A |